SECTION III - SHOULD SEPARATE END-POINT TRIALS BE REQUIRED FOR ALL LIPID-LOWERING DRUGS ACTING BY THE SAME MECHANISM - SECTION III DISCUSSION

Citation
Dm. Black et al., SECTION III - SHOULD SEPARATE END-POINT TRIALS BE REQUIRED FOR ALL LIPID-LOWERING DRUGS ACTING BY THE SAME MECHANISM - SECTION III DISCUSSION, The American journal of cardiology, 81(8A), 1998, pp. 92-94
Citations number
NO
Language
INGLESE
art.tipo
Editorial Material
Categorie Soggetti
Cardiac & Cardiovascular System
ISSN journal
0002-9149
Volume
81
Issue
8A
Year of publication
1998
Pages
92 - 94
Database
ISI
SICI code
0002-9149(1998)81:8A<92:SI-SSE>2.0.ZU;2-R